Dear EAN members, It is my pleasure to share with you some exciting news about EANpages.

For May 2019, we have selected: Fancourt D & Steptoe A. Television viewing and cognitive decline in older age: findings from the English Longitudinal Study of Ageing. Scientific Reports 2019;9:2851.

Slovenia is in southern central Europe, covering an area of 20,000 km2 with a population of approximately two million people with 163 licenced neurologists.

The Brain, Mind and Pain (BMP) initiative has today launched its Book of Evidence for the 2019-2024 European Parliament term.

On 27 March, the European Parliament and the Council reached an agreement on the EU's future framework programme for research and innovation, the Horizon Europe.

The publication “SumEMos: Análisis y propuestas para contribuir a normalizar la vida con EM” integrates all voices from the Multiple Sclerosis community in Spain. The document was released in the last weeks in conclusion of last year’s “SumEMos para normalizar la vida con EM” conference on 4 October.

ECNP Networks and Thematic Working Groups (TWGs)

Petr Mikulenka, MD, from Prgaue, Czechia Fellowship Term:  18.06 - 27.07.2018 Hosting department: Department of Neurology, Atkinson Morley Wing, St George’s Hospital, Blackshaw Road, Tooting, London SW17 0QT Supervisor: Dr. Anthony Pereira, Consultant Neurologist

Due to the successful debut of BrainChallenge in 2018, the EAN Teaching Course sub-Committee is organising the second edition of this entertaining and challenging Neurology Quiz during the upcoming EAN congress in Oslo in 2019.

Please find below articles from authors from Slovenia and co-authors that were published in the European Journal of Neurology

On 31 January 2019 , the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending the granting of a marketing authorisation for the medicinal product Ajovy©, intended for prophylaxis of migraine. The applicant for this medicinal product is Teva GmbH. The active substance is fremanezumab which is an antibody that works by binding to calcitonin gene-related peptide (CGRP). It is classified as an analgesic.

The 2019 Congress of the Academy for Multidisciplinary Neurotraumatology took place between April 11-12 in Cluj-Napoca, Romania, organized by the Foundation of the Society for the Study of Neuroprotection and Neuroplasticity and its partners.

On 21 March (Madrid, Spain), the new Innovative Medicines Initiative (IMI) coordination and support action entitled “Efficiently Networking European Neurodegeneration Research” (NEURONET) held its kick-off meeting.

The BioMed Alliance has provided feedback to the public consultation on Plan S, the initiative of the European Commission, Research Funding Organisations and Science Europe to promote open access publishing.

Sharing #LifeGoals has become a popular trend on social media. A campaign from the European Federation of Neurological Associations (EFNA) is putting a new spin on the trend by instead seeing patient advocates and supporters share their #BrainLifeGoals.